{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T11:35:36Z","timestamp":1782646536601,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["3R-US (33-7533-6-1522\/2\/3)"],"award-info":[{"award-number":["3R-US (33-7533-6-1522\/2\/3)"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["3R-US (33-7533-6-1522\/2\/3)"],"award-info":[{"award-number":["3R-US (33-7533-6-1522\/2\/3)"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["PM4Onco\u2013FKZ 01ZZ2322A"],"award-info":[{"award-number":["PM4Onco\u2013FKZ 01ZZ2322A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["PM4Onco\u2013FKZ 01ZZ2322A"],"award-info":[{"award-number":["PM4Onco\u2013FKZ 01ZZ2322A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["SATURN3 (01KD2206L)"],"award-info":[{"award-number":["SATURN3 (01KD2206L)"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1479 (Project ID 441891347-S1)"],"award-info":[{"award-number":["CRC1479 (Project ID 441891347-S1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1160 (Project ID 256073931-Z02)"],"award-info":[{"award-number":["CRC 1160 (Project ID 256073931-Z02)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR167 (Project ID 259373024-Z01)"],"award-info":[{"award-number":["TRR167 (Project ID 259373024-Z01)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 359 (Project ID 491676693-Z01)"],"award-info":[{"award-number":["TRR 359 (Project ID 491676693-Z01)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 353 (Project ID 471011418-SP02)"],"award-info":[{"award-number":["TRR 353 (Project ID 471011418-SP02)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 5476 UcarE (Project ID 493802833-P7)"],"award-info":[{"award-number":["FOR 5476 UcarE (Project ID 493802833-P7)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite recent medical advances, colorectal cancer (CRC) remains the second-leading cause of cancer-related death worldwide. For patients with KRAS wild-type metastatic CRC, the monoclonal antibody cetuximab, which targets the epidermal growth factor receptor (EGFR), is an approved treatment option. However, therapeutic success is often limited by the emergence of drug-resistant cancer cell populations within a few months. Therefore, alternative strategies to effectively target cetuximab-refractory CRC are urgently needed. Here, we sought to identify second-line therapeutic strategies using a CRC cell line with acquired cetuximab resistance as a model. Transcriptomic profiling of the resistant cells identified the apoptosis pathway as a potential therapeutic target, which was supported by their increased susceptibility to BH3-mimetics targeting the anti-apoptotic proteins MCL-1 and BCL-xL under both 2D and 3D culture conditions. These findings were validated in organotypic CRC slice cultures generated from cetuximab-resistant patient-derived xenografts (PDXs). Multiplex immunofluorescence staining demonstrated that BCL-xL inhibition effectively triggered apoptosis in heterogeneous PDX tumor slice models, including models harboring oncogenic BRAF mutations. Our findings suggest that cetuximab-resistant CRC retains apoptotic competence, and that BCL-xL inhibition serves as a robust alternative therapeutic strategy that is largely independent of the tumor mutational profile.<\/jats:p>","DOI":"10.1038\/s41419-026-08434-5","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:44:04Z","timestamp":1769838244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4418-8840","authenticated-orcid":false,"given":"Stella","family":"Asmanidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5437-8498","authenticated-orcid":false,"given":"Julia","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Ekstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schueler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-1943","authenticated-orcid":false,"given":"Patrick","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5621-0424","authenticated-orcid":false,"given":"Andreas C.","family":"Blaumeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-0602","authenticated-orcid":false,"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Wiebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronja","family":"Schiffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Essmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-1678","authenticated-orcid":false,"given":"Meng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-5805","authenticated-orcid":false,"given":"Steven A.","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Kontermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1093-263X","authenticated-orcid":false,"given":"Monilola A.","family":"Olayioye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"8434_CR1","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/jama.2021.6027","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer-Reply. JAMA. 2021;325:2405.","journal-title":"JAMA"},{"key":"8434_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.molonc.2014.05.003","volume":"8","author":"BO van Emburgh","year":"2014","unstructured":"van Emburgh BO, Sartore-Bianchi A, Di Nicolantonio F, Siena S, Bardelli A. Acquired resistance to EGFR-targeted therapies in colorectal cancer. Mol Oncol. 2014;8:1084\u201394.","journal-title":"Mol Oncol"},{"key":"8434_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/2159-8290.CD-17-0891","volume":"8","author":"KH Khan","year":"2018","unstructured":"Khan KH, Cunningham D, Werner B, Vlachogiannis G, Spiteri I, Heide T, et al. Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial. Cancer Discov. 2018;8:1270\u201385.","journal-title":"Cancer Discov"},{"key":"8434_CR4","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.3748\/wjg.v22.i28.6345","volume":"22","author":"V Sforza","year":"2016","unstructured":"Sforza V, Martinelli E, Ciardiello F, Gambardella V, Napolitano S, Martini G, et al. Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer. World J Gastroenterol. 2016;22:6345\u201361.","journal-title":"World J Gastroenterol"},{"key":"8434_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2468-1253(23)00479-X","volume":"9","author":"S Napolitano","year":"2024","unstructured":"Napolitano S, Martini G, Ciardiello D, Del Tufo S, Martinelli E, Troiani T, et al. Targeting the EGFR signalling pathway in metastatic colorectal cancer. Lancet Gastroenterol Hepatol. 2024;9:664\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8434_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/cancers12051214","volume":"12","author":"E Lai","year":"2020","unstructured":"Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, et al. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers. 2020;12:1214.","journal-title":"Cancers"},{"key":"8434_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.amjsurg.2016.02.013","volume":"212","author":"Y-Y Chang","year":"2016","unstructured":"Chang Y-Y, Lin P-C, Lin H-H, Lin J-K, Chen W-S, Jiang J-K, et al. Mutation spectra of RAS gene family in colorectal cancer. Am J Surg. 2016;212:537\u201344.e3.","journal-title":"Am J Surg"},{"key":"8434_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012;486:532\u20136.","journal-title":"Nature"},{"key":"8434_CR9","doi-asserted-by":"publisher","first-page":"224ra26","DOI":"10.1126\/scitranslmed.3007947","volume":"6","author":"S Misale","year":"2014","unstructured":"Misale S, Arena S, Lamba S, Siravegna G, Lallo A, Hobor S, et al. Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer. Sci Transl Med. 2014;6:224ra26.","journal-title":"Sci Transl Med"},{"key":"8434_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff M-A, Pereira RS, Pieper NM, et al. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther. 2025;10:91.","journal-title":"Signal Transduct Target Ther"},{"key":"8434_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04334-y","volume":"13","author":"D Fu","year":"2022","unstructured":"Fu D, Pfannenstiel L, Demelash A, Phoon YP, Mayell C, Cabrera C, et al. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma. Cell Death Dis. 2022;13:63.","journal-title":"Cell Death Dis"},{"key":"8434_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03092-7","volume":"11","author":"A-L Scherr","year":"2020","unstructured":"Scherr A-L, Mock A, Gdynia G, Schmitt N, Heilig CE, Korell F, et al. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer. Cell Death Dis. 2020;11:875.","journal-title":"Cell Death Dis"},{"key":"8434_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.drup.2007.08.002","volume":"10","author":"L Zhang","year":"2007","unstructured":"Zhang L, Ming L, Yu J. BH3 mimetics to improve cancer therapy; mechanisms and examples. Drug Resist Updat. 2007;10:207\u201317.","journal-title":"Drug Resist Updat"},{"key":"8434_CR14","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.3390\/ijms22083811","volume":"22","author":"Z Le","year":"2021","unstructured":"Le Z, Ramesh P, Steinmetz M, Medema JP. BH3 Mimetic Sensitivity of Colorectal Cancer Cell Lines in Correlation with Molecular Features Identifies Predictors of Response. Int J Mol Sci. 2021;22:3811.","journal-title":"Int J Mol Sci"},{"key":"8434_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06478-z","volume":"15","author":"LJ Jenkins","year":"2024","unstructured":"Jenkins LJ, Luk IY, Chionh F, Tan T, Needham K, Ayton J, et al. BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer. Cell Death Dis. 2024;15:183.","journal-title":"Cell Death Dis"},{"key":"8434_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep17187","volume":"5","author":"EJ Davies","year":"2015","unstructured":"Davies EJ, Dong M, Gutekunst M, N\u00e4rhi K, van Zoggel HJAA, Blom S, et al. Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices. Sci Rep. 2015;5:17187.","journal-title":"Sci Rep"},{"key":"8434_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1535-7163.MCT-21-0818","volume":"21","author":"A Rau","year":"2022","unstructured":"Rau A, Janssen N, K\u00fchl L, Sell T, Kalmykova S, M\u00fcrdter TE, et al. Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer. Mol Cancer Ther. 2022;21:799\u2013809.","journal-title":"Mol Cancer Ther"},{"key":"8434_CR18","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1002\/ijc.24604","volume":"125","author":"K Balmanno","year":"2009","unstructured":"Balmanno K, Chell SD, Gillings AS, Hayat S, Cook SJ. Intrinsic resistance to the MEK1\/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1\/2 signalling and\/or strong PI3K signalling in colorectal cancer cell lines. Int J Cancer. 2009;125:2332\u201341.","journal-title":"Int J Cancer"},{"key":"8434_CR19","doi-asserted-by":"publisher","first-page":"42183","DOI":"10.18632\/oncotarget.5619","volume":"6","author":"MK Kiessling","year":"2015","unstructured":"Kiessling MK, Curioni-Fontecedro A, Samaras P, Atrott K, Cosin-Roger J, Lang S, et al. Mutant HRAS as novel target for MEK and mTOR inhibitors. Oncotarget. 2015;6:42183\u201396.","journal-title":"Oncotarget"},{"key":"8434_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/1541-7786.MCR-14-0476","volume":"13","author":"K Okamoto","year":"2015","unstructured":"Okamoto K, Zaanan A, Kawakami H, Huang S, Sinicrope FA. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa\/Bik Induction and Bcl-2\/Bcl-xL Antagonism in Colon Cancer Cells. Mol Cancer Res. 2015;13:659\u201369.","journal-title":"Mol Cancer Res"},{"key":"8434_CR21","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1158\/1078-0432.CCR-08-1665","volume":"14","author":"K Okumura","year":"2008","unstructured":"Okumura K, Huang S, Sinicrope FA. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2\/Bcl-xL inhibitor, ABT-737. Clin Cancer Res. 2008;14:8132\u201342.","journal-title":"Clin Cancer Res"},{"key":"8434_CR22","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1182\/blood-2006-07-034173","volume":"109","author":"P P\u00e9rez-Gal\u00e1n","year":"2007","unstructured":"P\u00e9rez-Gal\u00e1n P, Rou\u00e9 G, Villamor N, Campo E, Colomer D. The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak. Blood. 2007;109:4441\u20139.","journal-title":"Blood"},{"key":"8434_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","volume":"51","author":"Z Hu","year":"2019","unstructured":"Hu Z, Ding J, Ma Z, Sun R, Seoane JA, Scott Shaffer J, et al. Quantitative evidence for early metastatic seeding in colorectal cancer. Nat Genet. 2019;51:1113\u201322.","journal-title":"Nat Genet"},{"key":"8434_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2024.100199","volume":"24","author":"F Alharbi","year":"2024","unstructured":"Alharbi F, Almanifi E, Ashrafuzzaman M. Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials. Med Drug Discov. 2024;24:100199. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590098624000241.","journal-title":"Med Drug Discov"},{"key":"8434_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"8434_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"8434_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"8434_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang T-C, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33:290\u20135.","journal-title":"Nat Biotechnol"},{"key":"8434_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"8434_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang","year":"2009","unstructured":"Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"8434_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318.","journal-title":"J Stat Softw"},{"key":"8434_CR32","unstructured":"Blighe, Rana, and Lewis. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling; 2018. https:\/\/github.com\/kevinblighe\/EnhancedVolcano"},{"key":"8434_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08434-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:40:01Z","timestamp":1770298801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08434-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8434"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08434-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were performed in an AAALAC-accredited facility and were in accordance with the Guide for the Care and Use of Laboratory Animals of the Society of Laboratory Animals (GV SOLAS). Animal experiments were approved by the Committee on the Ethics of Animal Experiments of the regional council (Regierungspr\u00e4sidium Freiburg, Abt. Landwirtschaft, L\u00e4ndlicher Raum, Veterin\u00e4r- und Lebensmittelwesen permit-#: I-19\/02 und G-23\/086).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"187"}}